نتائج البحث - Arwin Ridder

  • يعرض 1 - 5 نتائج من 5
تنقيح النتائج
  1. 1
    Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo‐ and tolterodine‐controlled phase 2 dose‐finding study

    Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo‐ and tolterodine‐controlled phase 2 dose‐finding study... حسب Christopher R. Chapple, Pedro Arañó, Jackie Bosch, Dirk De Ridder, A. E. J. L. Kramer, Arwin Ridder

    منشور في 2003
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    A proof‐of‐concept study: Mirabegron, a new therapy for overactive bladder

    A proof‐of‐concept study: Mirabegron, a new therapy for overactive bladder حسب Christopher R. Chapple, G. Amarenco, López Aramburu, Karel Everaert, J. Liehne, Malcolm G Lucas, Viktor Vik, Arwin Ridder, Robert Snijder, Osamu Yamaguchi

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (<scp>SYNERGY</scp> study)

    Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (<scp>SYNERGY</scp> study) حسب Sender Herschorn, Christopher R. Chapple, Paul Abrams, Salvador Arlandis, David Mitcheson, Kyu‐Sung Lee, Arwin Ridder, Matthias Stoelzel, Asha Paireddy, Rob van Maanen, Dudley Robinson

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    A phase II dose-ranging study of mirabegron in patients with overactive bladder

    A phase II dose-ranging study of mirabegron in patients with overactive bladder حسب Christopher R. Chapple, Vladimír Dvořák, P. Radziszewski, Philip Van Kerrebroeck, Jean Jacques Wyndaele, Brigitte Bosman, Peter J. Boerrigter, Ted Drogendijk, Arwin Ridder, Ingrid van der Putten-Slob, Osamu Yamaguchi

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II)

    Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (S... حسب Christian Gratzke, Rob van Maanen, Christopher R. Chapple, Paul Abrams, Sender Herschorn, Dudley Robinson, Arwin Ridder, Matthias Stoelzel, Asha Paireddy, Sang Jin Yoon, С Х Аль-Шукри, Tomasz Rechberger, Elizabeth R. Mueller

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: